Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Nephrology

Day-to-Day Management and Monitoring

At a Glance

FRTS3 requires individualized, lifelong monitoring of blood and urine mineral losses, kidney function, and bone health. Regular follow-up helps clinicians adjust supplements and detect complications such as dehydration, high urine calcium, kidney stones, or calcium deposits in the kidneys.

Managing Fanconi renotubular syndrome 3 (FRTS3) is a lifelong journey of careful observation. Because your kidneys are constantly losing essential minerals, your body’s balance can change quickly [1]. Regular monitoring is not just about checking for problems; it is about fine-tuning your supplements to keep your bones strong and to manage complications [2][3].

Building Your Multidisciplinary Care Team

Because FRTS3 affects both the kidneys and the skeletal system, you may need a team of specialists who collaborate closely [3][4].

  • Nephrologist: This is your primary lead. They monitor your kidney function and manage your electrolyte and bicarbonate levels [3][1].
  • Metabolic Bone Specialist or Endocrinologist: They specialize in how your body uses minerals like phosphate and calcium to build bone [3].
  • Genetic Counselor: Essential for understanding the inheritance pattern and helping other family members evaluate testing options [5].
  • Registered Dietitian: Helps you manage your intake of sodium, potassium, and fluids, which can be challenging when taking high doses of supplements [6].

The Surveillance Schedule

There is no “one-size-fits-all” schedule or established FRTS3-specific guideline [7][2]. The frequency of these labs will be individualized based on your age, current therapy, and kidney function.

Routine Lab Monitoring

Depending on your clinical needs, your team will periodically check:

  • Electrolytes and Bicarbonate: To ensure your acid-base balance is stable and your potassium levels are safe [3][1].
  • Phosphate, Calcium, and Magnesium: To monitor wasting and ensure blood levels are safe [2][8].
  • Alkaline Phosphatase (ALP): High levels of this enzyme can be a sign that your bones are under stress or that rickets is active [2][9].
  • PTH (Parathyroid Hormone): This hormone helps regulate calcium and phosphate [2][3].
  • Creatinine and eGFR: These measure your kidney’s overall “filtering” speed, which helps track overall kidney function [5][10].

Urine Studies

Urine tests demonstrate what the proximal tubules are losing:

  • Urinary Calcium: This is a critical safety check. If your urine calcium is too high (hypercalciuria), it can lead to kidney stones or calcium deposits [11][2].
  • Tubular Markers: Tests for sugar (glucose) and low-molecular-weight proteins demonstrate the extent of tubular dysfunction [10][12].

Protecting Bone and Kidney Health

Beyond blood work, your team will use imaging and physical assessments to monitor your progress.

  • Growth Tracking (Pediatrics): For children, measuring height and weight regularly is an important way to see if treatment is supporting normal growth [3][8].
  • Renal Ultrasound: Doctors use ultrasound when clinically indicated to look for nephrocalcinosis (calcium deposits) or stones in the kidney tissue [11][2].
  • Bone Imaging: Targeted radiographs (X-rays) can check for healing in rickets [9]. In adults, a DXA scan may be used to measure bone mineral density when clinically indicated, though it does not diagnose osteomalacia on its own [13].

When to Increase Monitoring

You may need more frequent labs during certain “high-risk” times [7][2]:

  • When starting or changing the dose of a medication.
  • During a growth spurt in childhood or puberty.
  • If you have a fever, vomiting, or diarrhea, which can cause rapid dehydration [14][15].
  • If you notice new symptoms like muscle weakness or increased bone pain.

Always keep a copy of your most recent labs. In a rare disease like FRTS3, you are often the most consistent expert on your own health journey, and having your records ready can help any doctor provide better care in an emergency [1].

Common questions in this guide

Which blood tests are used to monitor FRTS3?
Clinicians may check electrolytes, bicarbonate, phosphate, calcium, magnesium, alkaline phosphatase, parathyroid hormone, creatinine, and eGFR. The specific tests and timing depend on your age, kidney function, symptoms, and current treatment.
How often do people with FRTS3 need monitoring?
There is no single testing schedule for everyone with FRTS3. Monitoring may become more frequent after a medication or supplement change, during childhood growth, or during illness such as fever, vomiting, or diarrhea.
Why is urine calcium monitored in FRTS3?
High urine calcium can increase the risk of kidney stones and calcium deposits in the kidney tissue. Urine tests also look for substances such as glucose and small proteins that show how the kidney tubules are functioning.
Which specialists should be involved in FRTS3 care?
A nephrologist commonly coordinates care and monitors kidney function and mineral balance. An endocrinologist or metabolic bone specialist, genetic counselor, and registered dietitian may also contribute to bone care, family testing, and nutrition or supplement planning.
What should I do if vomiting or diarrhea makes it hard to take my supplements?
Ask your healthcare team for a written sick-day plan before an illness occurs. Vomiting and diarrhea can cause dehydration and rapidly change mineral levels, so contact your care team promptly and follow the individualized instructions rather than changing doses on your own.
How are bone health and growth tracked in FRTS3?
Children may have regular height and weight measurements to assess growth. Depending on symptoms and clinical needs, doctors may use X-rays to follow rickets, kidney ultrasound to look for stones or calcium deposits, or a DXA scan to measure bone mineral density in adults.

Get notified when new evidence is published on Fanconi renotubular syndrome 3.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Fanconi Syndrome.

    Foreman JW

    Pediatric clinics of North America 2019; (66(1)):159-167 doi:10.1016/j.pcl.2018.09.002.

    PMID: 30454741
  2. 2

    Rickets guidance: part II-management.

    Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

    Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

    PMID: 35352187
  3. 3

    Management of bone disease in cystinosis: Statement from an international conference.

    Hohenfellner K, Rauch F, Ariceta G, et al.

    Journal of inherited metabolic disease 2019; (42(5)):1019-1029 doi:10.1002/jimd.12134.

    PMID: 31177550
  4. 4

    [Cystinosis in adults: A systemic disease].

    Servais A, Goizet C, Bertholet-Thomas A, et al.

    Nephrologie & therapeutique 2015; (11(3)):152-9.

    PMID: 25769364
  5. 5

    A puzzling renal Fanconi syndrome.

    Haydock L, Hureaux M, Hoffmann M, et al.

    Clinical kidney journal 2025; (18(8)):sfae408 doi:10.1093/ckj/sfae408.

    PMID: 40800210
  6. 6

    Cystinosis-associated metabolic bone disease: pathogenesis and outcome.

    Schön A, Szaroszyk M, Haffner D

    Pediatric nephrology (Berlin, Germany) 2026; doi:10.1007/s00467-026-07518-w.

    PMID: 42697975
  7. 7

    Refractory Rickets: Evaluation and Management.

    Krishnamurthy S

    Indian journal of pediatrics 2026; (93(6)):612-620 doi:10.1007/s12098-026-06032-z.

    PMID: 41741919
  8. 8

    Targeting Hypercalciuria in SLC34A1-Related Disorders: Impact of Oral Phosphate Therapy and Novel Genetic Insights in Pediatric Case Series.

    Turan I, Atar M, Eltan M, et al.

    Calcified tissue international 2026; (117(1)):10 doi:10.1007/s00223-025-01462-x.

    PMID: 41543768
  9. 9

    Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene.

    Improda N, Rosanio FM, Annicchiarico Petruzzelli L, et al.

    Frontiers in endocrinology 2025; (16()):1553032 doi:10.3389/fendo.2025.1553032.

    PMID: 40225330
  10. 10

    Phenotypic Spectrum of HNF4α-Associated Fanconi Renotubular Syndrome.

    Emma F, Böckenhauer D, Mallett AJ, et al.

    Kidney international reports 2026; (11(8)):106616 doi:10.1016/j.ekir.2026.106616.

    PMID: 42440446
  11. 11

    Skeletal Consequences of Nephropathic Cystinosis.

    Florenzano P, Ferreira C, Nesterova G, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(10)):1870-1880 doi:10.1002/jbmr.3522.

    PMID: 29905968
  12. 12

    Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia.

    Ragate DC, Memon SS, Karlekar M, et al.

    Journal of bone and mineral metabolism 2024; (42(2)):155-165 doi:10.1007/s00774-023-01490-3.

    PMID: 38310177
  13. 13

    Changes in Bone Mineral Density Following Conventional Oral Phosphonate Treatment of Hypophosphatemic Osteomalacia: A Non-Randomized Controlled Study.

    Guo Y, Zhou YH, Wu XP, et al.

    International journal of general medicine 2021; (14()):7925-7931 doi:10.2147/IJGM.S332534.

    PMID: 34795510
  14. 14

    Fanconi syndrome, diabetes insipidus, and acute kidney injury due to tenofovir disoproxil fumarate: A case report.

    Zilwa N, Mpejane O, Mehboob G, et al.

    Antiviral therapy 2023; (28(3)):13596535231186727 doi:10.1177/13596535231186727.

    PMID: 37368845
  15. 15

    A Complicated Pregnancy in an Adult with HNF4A p.R63W-Associated Fanconi Syndrome.

    Anyiam O, Wallin E, Kaplan F, Lawrence C

    Case reports in medicine 2019; (2019()):2349470 doi:10.1155/2019/2349470.

    PMID: 31949432

This page explains day-to-day monitoring for FRTS3 for educational purposes. Your nephrologist and other specialists should determine your testing schedule, supplement changes, and sick-day plan.